ATE327749T1 - Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie - Google Patents
Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämieInfo
- Publication number
- ATE327749T1 ATE327749T1 AT03777932T AT03777932T ATE327749T1 AT E327749 T1 ATE327749 T1 AT E327749T1 AT 03777932 T AT03777932 T AT 03777932T AT 03777932 T AT03777932 T AT 03777932T AT E327749 T1 ATE327749 T1 AT E327749T1
- Authority
- AT
- Austria
- Prior art keywords
- prophylaxis
- treatment
- hypoestoxides
- hyperlipidemia
- agonists
- Prior art date
Links
- 208000031226 Hyperlipidaemia Diseases 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 239000000556 agonist Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 229930004069 diterpene Natural products 0.000 abstract 1
- -1 diterpene compound Chemical class 0.000 abstract 1
- 208000006575 hypertriglyceridemia Diseases 0.000 abstract 1
- HNPAHGHFONBTLV-KSJQNFQUSA-N hypoestoxide Chemical compound CC(=O)O[C@@H]1C[C@]2(C)O[C@H]2CC[C@]2(C)O[C@H]2C[C@@H]2CC(=O)C(=C)[C@@H]1C2(C)C HNPAHGHFONBTLV-KSJQNFQUSA-N 0.000 abstract 1
- HNPAHGHFONBTLV-UHFFFAOYSA-N hypoestoxide Natural products CC(=O)OC1CC2(C)OC2CCC2(C)OC2CC2CC(=O)C(=C)C1C2(C)C HNPAHGHFONBTLV-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42153302P | 2002-10-28 | 2002-10-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE327749T1 true ATE327749T1 (de) | 2006-06-15 |
Family
ID=32230237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03777932T ATE327749T1 (de) | 2002-10-28 | 2003-10-28 | Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20040087553A1 (de) |
| EP (1) | EP1558240B1 (de) |
| CN (1) | CN1731992A (de) |
| AT (1) | ATE327749T1 (de) |
| AU (1) | AU2003286721A1 (de) |
| BR (1) | BR0306632A (de) |
| CA (1) | CA2509834A1 (de) |
| DE (1) | DE60305727T2 (de) |
| WO (1) | WO2004039362A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7229979B2 (en) * | 2003-06-23 | 2007-06-12 | Immune Modulation, Inc. | Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents |
| US20060094695A1 (en) * | 2004-11-02 | 2006-05-04 | Paraquest, Inc. | Hypoestoxides, derivatives and agonists thereof for use in the prophylaxis and treatment of obesity |
| CN107530312A (zh) * | 2015-03-09 | 2018-01-02 | 免疫调节公司 | 用于治疗或预防神经退行性疾病的枪刀药素氧化物、其衍生物、相关化合物和激动剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) * | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| US5801193A (en) * | 1997-04-15 | 1998-09-01 | Immune Modulation, Inc. | Compositions and methods for immunosuppressing |
| US6001871A (en) * | 1998-01-15 | 1999-12-14 | Immune Modulation, Inc. | Hypoestoxides, derivatives and agonists thereof for use as antiviral agents |
| US5994328A (en) * | 1998-01-14 | 1999-11-30 | Immune Modulation, Inc. | Hypoestoxides, derivatives and agonists thereof for use as anticancer agents |
| US6242484B1 (en) * | 1999-07-06 | 2001-06-05 | Paraquest, Inc. | Hypoestoxides, derivatives and agonists thereof for use of antiparasitic agents |
-
2003
- 2003-10-28 DE DE60305727T patent/DE60305727T2/de not_active Expired - Fee Related
- 2003-10-28 BR BR0306632-0A patent/BR0306632A/pt not_active Application Discontinuation
- 2003-10-28 AT AT03777932T patent/ATE327749T1/de not_active IP Right Cessation
- 2003-10-28 EP EP03777932A patent/EP1558240B1/de not_active Expired - Lifetime
- 2003-10-28 WO PCT/US2003/034157 patent/WO2004039362A2/en not_active Application Discontinuation
- 2003-10-28 CN CNA2003801078605A patent/CN1731992A/zh active Pending
- 2003-10-28 US US10/694,934 patent/US20040087553A1/en not_active Abandoned
- 2003-10-28 CA CA002509834A patent/CA2509834A1/en not_active Abandoned
- 2003-10-28 AU AU2003286721A patent/AU2003286721A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60305727T2 (de) | 2007-05-31 |
| EP1558240B1 (de) | 2006-05-31 |
| CN1731992A (zh) | 2006-02-08 |
| DE60305727D1 (de) | 2006-07-06 |
| EP1558240A2 (de) | 2005-08-03 |
| US20040087553A1 (en) | 2004-05-06 |
| BR0306632A (pt) | 2004-09-28 |
| WO2004039362A2 (en) | 2004-05-13 |
| CA2509834A1 (en) | 2004-05-13 |
| WO2004039362A3 (en) | 2004-07-08 |
| AU2003286721A1 (en) | 2004-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0203713D0 (sv) | Novel compounds | |
| ATE548035T1 (de) | Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat | |
| DE50310516D1 (de) | Fredericamycin-derivate | |
| ATE453393T1 (de) | Verwendung von pyridylamiden als angiogenesehemmer | |
| BRPI0410727A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| NO307253B1 (no) | Fenylheterosykluser som syklooksygenase-2-inhibitorer | |
| DE60118003D1 (de) | Harnstoffderivate und ihre verwendung | |
| BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
| BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
| TW200608979A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
| EA200702674A1 (ru) | Способ лечения атеросклероза, дислипидемий и связанных с ними состояний и фармацевтические композиции | |
| DK1206474T3 (da) | Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer | |
| DE60112766D1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
| BR0309343A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| BR0309342A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| MY146509A (en) | Novel use of peptide compounds for treating essential tremor and other tremor syndromes | |
| ATE400564T1 (de) | Ppar alpha selektive verbindungen zur behandlung von dyslipidämie und anderen lipidstörungen | |
| BRPI0411085A (pt) | composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de vìrus oncogênicos, e de condições ou distúrbios devidos a infecção por hpv | |
| HRP20050103A2 (en) | N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| DE69918972D1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| MXPA05013226A (es) | Carbamatos de piperidina sustituidos, para el uso como inhibidores de la lipasa sensible a hormonas. | |
| BRPI0408117A (pt) | compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos | |
| EA200601120A1 (ru) | N-арилпиперидинзамещённые бифинилкарбоксамиды в качестве ингибиторов аполипопротеина в | |
| ES2345882T3 (es) | Nuevos compuestos y su uso como moduladores de ppar. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |